Research

Cancer; Clinical Trials; Research

Targeting Phosphatidylserine to Boost Immunotherapy Activity

February 5, 2025

Latest

Radiation Oncology Clinical Trials Home In on Personalized Treatments

January 22, 2025

The Rise of Theranostics: A 40-Year Journey

January 15, 2025

Fluorescent Nanoprobe Produces ‘Breakthrough’ for Peritoneal Metastases

November 15, 2023

Therapeutic Targeting of Septin Proteins: A New Pan-Cancer Focus?

October 25, 2023

Preventing Lineage Plasticity in Prostate Cancer Cells Resensitizes Them to Therapy

May 3, 2023

Targeting Lactate Metabolism for Cancer Immunotherapy

New study suggests that lactate can rejuvenate immune cells in the fight against cancer and may have additional benefits for immunotherapy.

March 29, 2023

Clinical Trials; Research

Grants Awarded to Expand Clinical Trials Navigation

Simmons Cancer Center researchers have received funding to help patients from diverse backgrounds access and navigate clinical trials.

March 22, 2023

Lung Cancer; Research

AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC

New Simmons Cancer Center research involving investigational drug to target AXL inhibition shows possible benefits for patients with lung adenocarcinomas.

August 15, 2022

Research; Neuro Oncology

Novel Biomarker-Guided Therapeutics Target Glioma Origins

Simmons has pioneered a new patient-derived organoid model of lower-grade glioma capable of identifying biomarker-guided therapeutic strategies poised for clinical translation.

April 5, 2023

All Articles